SCHEMBL3066265

SCHEMBL3066265

CC(C(N)=O)c1cccc2c1CCCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.44
BAD Q92934 1/20 0.44
ALDH1A1 P00352 4/20 0.42
LMNA P02545 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CXCL8 P10145 1/20 0.41
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.39
HPGD P15428 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL299539 0.85 BCL2L1 (0.46) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL12930757 0.83 ALDH1A1 (0.44) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL24469462 0.78 BCL2L1 (0.47) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL20510102 0.78 BCL2L1 (0.47) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL17154225 0.78 BCL2L1 (0.52) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL19682589 0.77 BCL2L1 (0.41) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL20889215 0.77 BCL2L1 (0.41) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL19682588 0.77 BCL2L1 (0.41) BCL2L1BADALDH1A1LMNAMEN1
SCHEMBL18540425 0.77 BCL2L1 (0.50) BCL2L1BADALDH1A1LMNAMEN1
Hydrochloric Acid SCHEMBL29043115 0.76 BCL2L1 (0.46) BCL2L1BADALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267697-A1 ION CHANNEL MODULATORS CACNA1E, CACNA1A, CACNA1S BCL2L1 1742/4885BAD 954/4885ALDH1A1 957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.